… possible to ease LF via enhancing DC immunosuppression. To further explore this, we
detected the role of KD in LF therapy … The results suggested that KD exhibited attenuated effects …

… Dendritic cells (DCs), a type of highly efficient antigen-… cells are activated to induce autoimmune
hepatitis (AIH) in mice … by KD in the model of autoimmune hepatitis, while it was reported …

… and nontoxic properties, KD has the potential to be a novel and effective drug to treat NASH.
… attenuated autoimmune hepatitis or liver fibro-inflammation by suppressing dendritic cells …

… to the standard immunosuppressive therapy of steroids and … 200 potential targets of
costunolide. Using the search word “… , PI3K-AKT pathway is activated in hepatocytes and dendritic …

… in autoimmune liver diseases like autoimmune hepatitis [Citation… This study found that
kinsenoside is able to inhibit DCs … the gene or drug level, the possible side effects should be fully …

… , the liver protective effects and potential mechanisms of KD in alcoholic liver disease (ALD) …
This study aimed to investigate the liver protective activity and potential mechanisms of KD …

… found to be a potential immunosuppressive drug which could disrupt dendritic cells (DC)-induced
cross-priming of CD8 + T cell responses in treatment of autoimmune hepatitis (AIH) 49 …

… It has been demonstrated that Kinsenoside (KD, the … that has multiple pharmacological effects
on anti-hyperlipidemia [26… the effect of KD against EIC, and further understand the potential …

… Hepatic dendritic cells represent a unique and multifaceted subset of antigen-presenting …
kinsenoside as a potential immunosuppressive drug for autoimmune hepatitis: Kinsenoside is a …

… some may interact with medications or have potential side effects. 4.5 Target dendritic
cells … , several other drugs have demonstrated potential therapeutic effects on MAFLD by …